MRK, ABBV, PXD, VBR and VIOO

MRK, ABBV, PXD, VBR and VIOO

For Immediate Release

Chicago, IL – September 10, 2020 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/1055908/generation-x-investors-deja-vu)

Welcome to Episode #240 of the Zacks Market Edge Podcast.

Market Edge From Zacks · Generation X Investors: Deja Vu?

 

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

This week, Tracey is going solo to talk about the summer stock market rally.” data-reactid=”25″>This week, Tracey is going solo to talk about the summer stock market rally.

As a Generation Xer herself, this rally is beginning to have a sense of déjà vu with the late 1990s.

In 2000, the NASDAQ was coming off its best year of the decade, up 85.6%. Everyone was diving into technology, as they chased the returns of the past 5 years.

It was a new era of the Internet and dot coms. Everyone thought the innovation would go on forever. If you didn’t own tech in 2000, you were a loser.

Flash forward to 2020. Just before the pandemic, the NASDAQ was hot and hitting new highs in February. But then the coronavirus hit.

Off the March coronavirus lows, however, the NASDAQ rallied over 75% to another set of new all-time highs, until the recent 9% pullback.

Millions of new traders and investors have opened up accounts on trading apps like Robinhood.

In 1999, eTrade, which allowed you to trade cheaply online, was also adding millions of new accounts and traders.  

Good investors have a diverse portfolio. They’re not just in technology.

Some industries have value and aren’t getting sold off as sharply right now as tech or the popular growth names.

Where should you look?

Big cap pharmaceuticals have underperformed this year and for the last 5 years. The industry is up just 52% over the last 5 years compared to a gain of 91.7% for the S&P 500.

Energy, value and small caps are also in the dog house.

What else should you know about investing during the NASDAQ bull market and pullback?

Listen to this week’s podcast to find out.

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Click to get this free report
 
Pioneer Natural Resources Company (PXD) : Free Stock Analysis Report
 
Merck Co., Inc. (MRK) : Free Stock Analysis Report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
Vanguard SmallCap Value ETF (VBR): ETF Research Reports
 
Vanguard SP SmallCap 600 ETF (VIOO): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research” data-reactid=”65″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pioneer Natural Resources Company (PXD) : Free Stock Analysis Report
 
Merck Co., Inc. (MRK) : Free Stock Analysis Report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
Vanguard SmallCap Value ETF (VBR): ETF Research Reports
 
Vanguard SP SmallCap 600 ETF (VIOO): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Source Article